Skip to Main Content

Paper Details

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Eur Urol Oncol
36
2021
Advanced Urothelial Carcinoma, PARTICIPANTS, PATIENT, PD-L1, Patients, UC, aUC, advanced urothelial cancer, advanced urothelial carcinoma, albumin, carboplatin, cisplatin, liver metastases, lymphocyte, neutrophil, patient, patients, platinum, programmed death-ligand 1, tumor, tumors
Author NameAffiliation
Neeraj AgarwalUniversity of Utah
Alexandra DrakakiDavid Geffen School of Medicine at university of california los angeles
Jure MurgicUniversity Hospital Center Sestre Milosrdnice
Pedro Isaacsson VelhoSidney Kimmel Comprehensive Cancer Center
Matthew D GalskyIcahn School of Medicine at Mount Sinai
Evan Y YuFred Hutchinson Cancer Research Center, University of Washington
  • 1 - 6

Datasets

Release 1.2